# The Mechanism of Ferroptosis and Blood–Brain Barrier Damage in Cerebrovascular Diseases

**Authors:** Jiaxin Guo, Chengye Yao

PMC · DOI: 10.3390/biomedicines14030604 · Biomedicines · 2026-03-09

## TL;DR

This paper explores how ferroptosis, a type of cell death, contributes to blood-brain barrier damage in cerebrovascular diseases and suggests targeting it could help protect the brain.

## Contribution

The paper highlights ferroptosis as a novel mechanism underlying blood-brain barrier dysfunction in cerebrovascular diseases.

## Key findings

- Ferroptosis affects multiple brain cell types and contributes to blood-brain barrier disruption.
- Targeting ferroptosis may protect the blood-brain barrier and reduce neuroinflammation.
- Ferroptosis is a major pathway in various cerebrovascular diseases.

## Abstract

The blood–brain barrier (BBB) is a vital protective structure that prevents harmful substances in the blood from entering the central nervous system while maintaining homeostasis. Its dysfunction can lead to significant pathological changes and contribute to various neurological disorders, such as stroke and neurodegenerative diseases. BBB damage of varying degrees is observed in nearly all cerebrovascular diseases, yet the specific mechanisms remain largely unclear. Growing evidence indicates that ferroptosis—an iron-dependent, lipid peroxidation-driven form of regulated cell death—is a major pathway contributing to BBB disruption. Ferroptosis affects multiple key brain cell types, including endothelial cells, glial cells, pericytes, and neurons, potentially leading to BBB dysfunction in cerebrovascular diseases. This article explores the role of ferroptosis in different types of cerebrovascular diseases and its effects on various cells. It covers the latest research in this area and highlights the potential benefits of targeting ferroptosis, including protecting the blood–brain barrier, reducing neuroinflammation, and protecting neurons.

## Linked entities

- **Diseases:** stroke (MONDO:0005098)

## Full-text entities

- **Diseases:** Cerebrovascular Diseases (MESH:D002561), stroke (MESH:D020521), neurological disorders (MESH:D009461), neuroinflammation (MESH:D000090862), BBB damage (MESH:C536830), neurodegenerative diseases (MESH:D019636)
- **Chemicals:** iron (MESH:D007501), lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023801/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023801/full.md

## References

126 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023801/full.md

---
Source: https://tomesphere.com/paper/PMC13023801